CLGM
ONC icon

Capitolis Liquid Global Markets’s BeOne Medicines Ltd ONC Stock Holding History

Capitolis Liquid Global Markets’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,900
Closed -$5.96M – 315
2025
Q1 		$5.96M Buy
+21,900
New +$5.12M 0.05% 161

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capitolis Liquid Global Markets's ONC Position: Q2 2025 in Review

Capitolis Liquid Global Markets sold out of BeOne Medicines Ltd (ONC) in Q2 2025, closing a stake of 21,900 shares — an estimated $5.96M sold.

Capitolis Liquid Global Markets first reported a position in ONC in Q1 2025 and held it in 1 quarter. The position peaked at $5.96M in Q1 2025. 245 funds tracked by Wall St. Rank hold ONC as of Q2 2025.

  • Capitolis Liquid Global Markets reported no remaining BeOne Medicines Ltd position as of Q2 2025 after selling out during the quarter.
  • Capitolis Liquid Global Markets sold 21,900 BeOne Medicines Ltd shares in Q2 2025, an estimated $5.96M.
  • Capitolis Liquid Global Markets first reported a position in BeOne Medicines Ltd in Q1 2025 and held it in 1 quarter.
  • Capitolis Liquid Global Markets's BeOne Medicines Ltd position peaked at $5.96M in Q1 2025.
  • 245 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2025.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2025, filed 14 Aug 2025.